12 Health Care Stocks Moving In Friday's After-Market Session
NRX Pharmaceuticals Inc NRXP
$3.15
▲ +0.96%
(+$0.03)
⬆️ Above Yest. High
🎢 High Beta
Open
$3.16
Prev Close
$3.12
Day Range
$2.95 – $3.30
52W Range
$1.62 – $5.06
Market Cap
$132.12M
Beta
2.17
EPS (TTM)
$-1.28
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2017-11-20 |
| Shares Out. | 36,230,000 |
| Website | nrxpharma.com/ ↗ |
| Phone | 13025750877 |
| Employees | 29 |
| Revenue | $1.1M |
| Gross Profit | $437,000 |
| Net Income | -$1.4M |
| Total Assets | $11.9M |
| Total Liabilities | $25.7M |
| Equity | -$13.8M |
About NRX Pharmaceuticals Inc
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
NRX Pharmaceuticals Inc is a publicly traded company under the ticker symbol NRXP on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-07-01)